Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases
Cardiovascular disease (CVD) is the leading cause of death globally for men and women. Premenopausal women have a lower incidence of hypertension and other cardiovascular events than men of the same age, but diminished sex differences after menopause implicates 17-beta-estradiol (E2) as a protective...
Gespeichert in:
Veröffentlicht in: | Journal of human hypertension 2023-08, Vol.37 (8), p.609-618 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 618 |
---|---|
container_issue | 8 |
container_start_page | 609 |
container_title | Journal of human hypertension |
container_volume | 37 |
creator | Visniauskas, Bruna Kilanowski-Doroh, Isabella Ogola, Benard O. Mcnally, Alexandra B. Horton, Alec C. Imulinde Sugi, Ariane Lindsey, Sarah H. |
description | Cardiovascular disease (CVD) is the leading cause of death globally for men and women. Premenopausal women have a lower incidence of hypertension and other cardiovascular events than men of the same age, but diminished sex differences after menopause implicates 17-beta-estradiol (E2) as a protective agent. The cardioprotective effects of E2 are mediated by nuclear estrogen receptors (ERα and ERβ) and a G protein-coupled estrogen receptor (GPER). This review summarizes both established as well as emerging estrogen-mediated mechanisms that underlie sex differences in the vasculature during hypertension and CVD. In addition, remaining knowledge gaps inherent in the association of sex differences and E2 are identified, which may guide future clinical trials and experimental studies in this field. |
doi_str_mv | 10.1038/s41371-022-00771-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10919324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2731429560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-1c3468921798da432c9c3c09052648beb654ba642763bf5653e892f1d7c719593</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EoqXwBzigSFy4BPzt-IRQVT6kqlzas-U4s7uuEnvxJJX67-uwpRQO9cWW5_HjGb2EvGX0I6Oi-4SSCcNaynlLqVlPz8gxk0a3SnHz_NH5iLxCvKZ0vehekiOhBbOd0sfk4gznkreQ2gmG6GcYmgnCzqeIEzYxNbvbPZQZEsacGp-GJs87KE3wZYj5xmNYRl-aISJ4BHxNXmz8iPDmfj8hV1_PLk-_t-c_v_04_XLeBmnU3LIgpO4sZ8Z2g5eCBxtEoJYqrmXXQ6-V7L2W3GjRb5RWAiq9YYMJhlllxQn5fPDul742HiDNxY9uX-Lky63LPrp_Kynu3DbfOEYts4LLavhwbyj51wI4uyligHH0CfKCjhvBJLdK04q-_w-9zktJdT7HO6msqWsV8gMVSkYssHnohlG35uUOebmal_udl1vV7x7P8fDkT0AVEAcAayltofz9-wntHZcaoMk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2845977774</pqid></control><display><type>article</type><title>Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Visniauskas, Bruna ; Kilanowski-Doroh, Isabella ; Ogola, Benard O. ; Mcnally, Alexandra B. ; Horton, Alec C. ; Imulinde Sugi, Ariane ; Lindsey, Sarah H.</creator><creatorcontrib>Visniauskas, Bruna ; Kilanowski-Doroh, Isabella ; Ogola, Benard O. ; Mcnally, Alexandra B. ; Horton, Alec C. ; Imulinde Sugi, Ariane ; Lindsey, Sarah H.</creatorcontrib><description>Cardiovascular disease (CVD) is the leading cause of death globally for men and women. Premenopausal women have a lower incidence of hypertension and other cardiovascular events than men of the same age, but diminished sex differences after menopause implicates 17-beta-estradiol (E2) as a protective agent. The cardioprotective effects of E2 are mediated by nuclear estrogen receptors (ERα and ERβ) and a G protein-coupled estrogen receptor (GPER). This review summarizes both established as well as emerging estrogen-mediated mechanisms that underlie sex differences in the vasculature during hypertension and CVD. In addition, remaining knowledge gaps inherent in the association of sex differences and E2 are identified, which may guide future clinical trials and experimental studies in this field.</description><identifier>ISSN: 1476-5527</identifier><identifier>ISSN: 0950-9240</identifier><identifier>EISSN: 1476-5527</identifier><identifier>DOI: 10.1038/s41371-022-00771-0</identifier><identifier>PMID: 36319856</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>17β-Estradiol ; 631/443/592/75/243 ; 631/443/7 ; Age ; Androgens ; Blood pressure ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - etiology ; Clinical trials ; Epidemiology ; Estradiol - pharmacology ; Estrogen receptors ; Estrogens ; Female ; Females ; Gender differences ; Health Administration ; Heart failure ; Humans ; Hypertension ; Hypertension - complications ; Hypertension - drug therapy ; Male ; Males ; Medicine ; Medicine & Public Health ; Menopause ; Metabolites ; Nitric oxide ; Public Health ; Receptors, Estrogen ; Receptors, G-Protein-Coupled ; Review Article ; Sex differences ; Smooth muscle ; Stroke ; Womens health</subject><ispartof>Journal of human hypertension, 2023-08, Vol.37 (8), p.609-618</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2022. The Author(s), under exclusive licence to Springer Nature Limited.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-1c3468921798da432c9c3c09052648beb654ba642763bf5653e892f1d7c719593</citedby><cites>FETCH-LOGICAL-c475t-1c3468921798da432c9c3c09052648beb654ba642763bf5653e892f1d7c719593</cites><orcidid>0000-0002-4525-2194 ; 0000-0003-4998-8171 ; 0000-0002-9837-4582</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36319856$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Visniauskas, Bruna</creatorcontrib><creatorcontrib>Kilanowski-Doroh, Isabella</creatorcontrib><creatorcontrib>Ogola, Benard O.</creatorcontrib><creatorcontrib>Mcnally, Alexandra B.</creatorcontrib><creatorcontrib>Horton, Alec C.</creatorcontrib><creatorcontrib>Imulinde Sugi, Ariane</creatorcontrib><creatorcontrib>Lindsey, Sarah H.</creatorcontrib><title>Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases</title><title>Journal of human hypertension</title><addtitle>J Hum Hypertens</addtitle><addtitle>J Hum Hypertens</addtitle><description>Cardiovascular disease (CVD) is the leading cause of death globally for men and women. Premenopausal women have a lower incidence of hypertension and other cardiovascular events than men of the same age, but diminished sex differences after menopause implicates 17-beta-estradiol (E2) as a protective agent. The cardioprotective effects of E2 are mediated by nuclear estrogen receptors (ERα and ERβ) and a G protein-coupled estrogen receptor (GPER). This review summarizes both established as well as emerging estrogen-mediated mechanisms that underlie sex differences in the vasculature during hypertension and CVD. In addition, remaining knowledge gaps inherent in the association of sex differences and E2 are identified, which may guide future clinical trials and experimental studies in this field.</description><subject>17β-Estradiol</subject><subject>631/443/592/75/243</subject><subject>631/443/7</subject><subject>Age</subject><subject>Androgens</subject><subject>Blood pressure</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Clinical trials</subject><subject>Epidemiology</subject><subject>Estradiol - pharmacology</subject><subject>Estrogen receptors</subject><subject>Estrogens</subject><subject>Female</subject><subject>Females</subject><subject>Gender differences</subject><subject>Health Administration</subject><subject>Heart failure</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - complications</subject><subject>Hypertension - drug therapy</subject><subject>Male</subject><subject>Males</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Menopause</subject><subject>Metabolites</subject><subject>Nitric oxide</subject><subject>Public Health</subject><subject>Receptors, Estrogen</subject><subject>Receptors, G-Protein-Coupled</subject><subject>Review Article</subject><subject>Sex differences</subject><subject>Smooth muscle</subject><subject>Stroke</subject><subject>Womens health</subject><issn>1476-5527</issn><issn>0950-9240</issn><issn>1476-5527</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kU1v1DAQhi0EoqXwBzigSFy4BPzt-IRQVT6kqlzas-U4s7uuEnvxJJX67-uwpRQO9cWW5_HjGb2EvGX0I6Oi-4SSCcNaynlLqVlPz8gxk0a3SnHz_NH5iLxCvKZ0vehekiOhBbOd0sfk4gznkreQ2gmG6GcYmgnCzqeIEzYxNbvbPZQZEsacGp-GJs87KE3wZYj5xmNYRl-aISJ4BHxNXmz8iPDmfj8hV1_PLk-_t-c_v_04_XLeBmnU3LIgpO4sZ8Z2g5eCBxtEoJYqrmXXQ6-V7L2W3GjRb5RWAiq9YYMJhlllxQn5fPDul742HiDNxY9uX-Lky63LPrp_Kynu3DbfOEYts4LLavhwbyj51wI4uyligHH0CfKCjhvBJLdK04q-_w-9zktJdT7HO6msqWsV8gMVSkYssHnohlG35uUOebmal_udl1vV7x7P8fDkT0AVEAcAayltofz9-wntHZcaoMk</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Visniauskas, Bruna</creator><creator>Kilanowski-Doroh, Isabella</creator><creator>Ogola, Benard O.</creator><creator>Mcnally, Alexandra B.</creator><creator>Horton, Alec C.</creator><creator>Imulinde Sugi, Ariane</creator><creator>Lindsey, Sarah H.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4525-2194</orcidid><orcidid>https://orcid.org/0000-0003-4998-8171</orcidid><orcidid>https://orcid.org/0000-0002-9837-4582</orcidid></search><sort><creationdate>20230801</creationdate><title>Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases</title><author>Visniauskas, Bruna ; Kilanowski-Doroh, Isabella ; Ogola, Benard O. ; Mcnally, Alexandra B. ; Horton, Alec C. ; Imulinde Sugi, Ariane ; Lindsey, Sarah H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-1c3468921798da432c9c3c09052648beb654ba642763bf5653e892f1d7c719593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>17β-Estradiol</topic><topic>631/443/592/75/243</topic><topic>631/443/7</topic><topic>Age</topic><topic>Androgens</topic><topic>Blood pressure</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Clinical trials</topic><topic>Epidemiology</topic><topic>Estradiol - pharmacology</topic><topic>Estrogen receptors</topic><topic>Estrogens</topic><topic>Female</topic><topic>Females</topic><topic>Gender differences</topic><topic>Health Administration</topic><topic>Heart failure</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - complications</topic><topic>Hypertension - drug therapy</topic><topic>Male</topic><topic>Males</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Menopause</topic><topic>Metabolites</topic><topic>Nitric oxide</topic><topic>Public Health</topic><topic>Receptors, Estrogen</topic><topic>Receptors, G-Protein-Coupled</topic><topic>Review Article</topic><topic>Sex differences</topic><topic>Smooth muscle</topic><topic>Stroke</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Visniauskas, Bruna</creatorcontrib><creatorcontrib>Kilanowski-Doroh, Isabella</creatorcontrib><creatorcontrib>Ogola, Benard O.</creatorcontrib><creatorcontrib>Mcnally, Alexandra B.</creatorcontrib><creatorcontrib>Horton, Alec C.</creatorcontrib><creatorcontrib>Imulinde Sugi, Ariane</creatorcontrib><creatorcontrib>Lindsey, Sarah H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of human hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Visniauskas, Bruna</au><au>Kilanowski-Doroh, Isabella</au><au>Ogola, Benard O.</au><au>Mcnally, Alexandra B.</au><au>Horton, Alec C.</au><au>Imulinde Sugi, Ariane</au><au>Lindsey, Sarah H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases</atitle><jtitle>Journal of human hypertension</jtitle><stitle>J Hum Hypertens</stitle><addtitle>J Hum Hypertens</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>37</volume><issue>8</issue><spage>609</spage><epage>618</epage><pages>609-618</pages><issn>1476-5527</issn><issn>0950-9240</issn><eissn>1476-5527</eissn><abstract>Cardiovascular disease (CVD) is the leading cause of death globally for men and women. Premenopausal women have a lower incidence of hypertension and other cardiovascular events than men of the same age, but diminished sex differences after menopause implicates 17-beta-estradiol (E2) as a protective agent. The cardioprotective effects of E2 are mediated by nuclear estrogen receptors (ERα and ERβ) and a G protein-coupled estrogen receptor (GPER). This review summarizes both established as well as emerging estrogen-mediated mechanisms that underlie sex differences in the vasculature during hypertension and CVD. In addition, remaining knowledge gaps inherent in the association of sex differences and E2 are identified, which may guide future clinical trials and experimental studies in this field.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>36319856</pmid><doi>10.1038/s41371-022-00771-0</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-4525-2194</orcidid><orcidid>https://orcid.org/0000-0003-4998-8171</orcidid><orcidid>https://orcid.org/0000-0002-9837-4582</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1476-5527 |
ispartof | Journal of human hypertension, 2023-08, Vol.37 (8), p.609-618 |
issn | 1476-5527 0950-9240 1476-5527 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10919324 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | 17β-Estradiol 631/443/592/75/243 631/443/7 Age Androgens Blood pressure Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - etiology Clinical trials Epidemiology Estradiol - pharmacology Estrogen receptors Estrogens Female Females Gender differences Health Administration Heart failure Humans Hypertension Hypertension - complications Hypertension - drug therapy Male Males Medicine Medicine & Public Health Menopause Metabolites Nitric oxide Public Health Receptors, Estrogen Receptors, G-Protein-Coupled Review Article Sex differences Smooth muscle Stroke Womens health |
title | Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T05%3A46%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Estrogen-mediated%20mechanisms%20in%20hypertension%20and%20other%20cardiovascular%20diseases&rft.jtitle=Journal%20of%20human%20hypertension&rft.au=Visniauskas,%20Bruna&rft.date=2023-08-01&rft.volume=37&rft.issue=8&rft.spage=609&rft.epage=618&rft.pages=609-618&rft.issn=1476-5527&rft.eissn=1476-5527&rft_id=info:doi/10.1038/s41371-022-00771-0&rft_dat=%3Cproquest_pubme%3E2731429560%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2845977774&rft_id=info:pmid/36319856&rfr_iscdi=true |